The editorial board is the journal's primary source of peer reviewers and members occasionally provide assistance to the editor in chief. The editor in chief welcomes applications from suitable candidates to join the editorial board. Further information on the editorial board is available here.
Youssef Al-Tonbary, PhD
Head of Pediatric Department, Mansoura University, Mansoura City, Egypt
Robert J. Amato, MD
Professor and Acting Director, Division of Oncology, University of Texas Medical School, Houston, Chief, Division of Oncology, Memorial Hermann Cancer Center, TMC, Houston, TX, USA
Priya Bhosale, MD
Assistant Professor, Department of Diagnostic Radiology, Division of Diagnostic Imaging, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA
Harry B. Burke, PhD, MD
Associate Professor, Internal Medicine, Uniformed Services University of the Health Sciences, Bethesda, Maryland, USA
Undurti N Das, MD, FAMS
President and CEO, UND Life Sciences, Shaker Heights, Ohio USA
Pier Francesco Ferrucci, MD
Director, Unit of Translational Research on Melanoma, Department of Medical Oncology, European Institute of Oncology, Milan, Italy
Stephen Hiscox, PhD
RCUK Academic Fellow, Welsh School of Pharmacy, Cardiff University, Cardiff, UK
Zhenyu Ji, MD, PhD
Translational Research Fellow, Dermatology, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts, USA
Maria Koehler, PhD
Vice President, Strategy Leader, Clinical Development and Medical Affairs, Pfizer Oncology Business Unit, Pfizer Inc., New York, USA
Tarun Mandal, PhD
McCaffrey/Norwood Professor of Pharmacy, Xavier University of Louisiana, New Orleans, Louisiana, USA
Daniele Santini, PhD, MD
Associate Professor in General Pathology, Medical Oncology, Università Campus Bio-Medico, Rome, Italy
Nishant Tageja, MD
Resident in Internal Medicine, Detroit Medical Center, Wayne State University, Detroit, Michigan, USA
Takuji Tanaka, PhD, MD
Director, The Tohkai Cytopathology Institute: Cancer Research and Prevention (TCI-CaRP), Gifu City, Gifu, Japan
Glenn Tisman, MD
Private Practice, Hematology/Oncology, Whittier, California, USA
Jay Vadgama, PhD
Associate Vice President for Research and Health Affairs & Professor of Medicine, UCLA School of Medicine, Los Angeles, California, USA
I was requested to contribute a review. The objectives, timelines and process were all extremely reasonable and fit in well with my knowledge base and my work as well as my schedule. The process was quite seamless and no paper was ever exchanged--everything was completed on-line. Thanks for the opportunity to make this contribution.
Facebook Google+ Twitter
Pinterest Tumblr YouTube